TOLREMO therapeutics


TOLREMO therapeutics is a developer of small molecules intended to target novel drug resistance pathways in cancer therapy.

Employees

1-10

Links


Org chart

Collapse
Jessica Corson
Chief Business Officer
Florian Vogl
Chief Medical Officer

Board & advisors


Teams

This company has no teams yet


Offices